International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
NCT ID: NCT00593229
Last Updated: 2013-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
6 participants
OBSERVATIONAL
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
NCT04745195
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652
Registry for Vascular Anomalies Associated With Coagulopathy
NCT00576888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients are seen intially and annually thereafter
Biosamples are collected for storage annually.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3
Familial atypical HUS
No interventions assigned to this group
4
Thrombotic thrombocytopenic purpura (TTP)
No interventions assigned to this group
1
Severe diarrhea-associated hemolytic uremic syndrome (D+HUS)
No interventions assigned to this group
2
Non-familial atypical HUS
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Philadelphia
OTHER
Mario Negri Institute for Pharmacological Research
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
University of Virginia
OTHER
Montreal Children's Hospital of the MUHC
OTHER
University of Utah
OTHER
Stollery Children's Hospital
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Howard Trachtman, MD
Role: PRINCIPAL_INVESTIGATOR
Schneider Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schneider Chldren's Hospital
New Hyde Park, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DK R21-71221
Identifier Type: -
Identifier Source: secondary_id
DK71221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.